These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 28971758)

  • 1. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
    Shekari N; Baradaran B; Shanehbandi D; Kazemi T
    Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis.
    Zhu X; Lv M; Wang H; Guan W
    Dig Dis Sci; 2014 May; 59(5):911-9. PubMed ID: 24337687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives.
    Mirzaei H; Khataminfar S; Mohammadparast S; Sales SS; Maftouh M; Mohammadi M; Simonian M; Parizadeh SM; Hassanian SM; Avan A
    Curr Med Chem; 2016; 23(36):4135-4150. PubMed ID: 27538692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening.
    Wang H; Wang L; Wu Z; Sun R; Jin H; Ma J; Liu L; Ling R; Yi J; Wang L; Bian J; Chen J; Li N; Yuan S; Yun J
    Med Oncol; 2014 Dec; 31(12):298. PubMed ID: 25367852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as diagnostic biomarkers in gastric cancer.
    Yin Y; Li J; Chen S; Zhou T; Si J
    Int J Mol Sci; 2012 Oct; 13(10):12544-55. PubMed ID: 23202912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
    Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
    Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
    Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
    Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in gastric cancer early diagnosis.
    Necula L; Matei L; Dragu D; Neagu AI; Mambet C; Nedeianu S; Bleotu C; Diaconu CC; Chivu-Economescu M
    World J Gastroenterol; 2019 May; 25(17):2029-2044. PubMed ID: 31114131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.
    Link A; Kupcinskas J
    World J Gastroenterol; 2018 Aug; 24(30):3313-3329. PubMed ID: 30122873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating cell-free DNAs and miRNAs as promising non-invasive biomarkers for early detection of gastric cancer.
    Liu X; Chu KM
    Neoplasma; 2016; 63(1):1-9. PubMed ID: 26639229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: a systematic literature review.
    Stojanovic J; Tognetto A; Tiziano DF; Leoncini E; Posteraro B; Pastorino R; Boccia S
    Biomarkers; 2019 Mar; 24(2):110-119. PubMed ID: 30387681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets.
    Wu X; Shen J; Xiao Z; Li J; Zhao Y; Zhao Q; Cho CH; Li M
    Biochem Pharmacol; 2019 May; 163():425-439. PubMed ID: 30857828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as potential biomarkers for gastric cancer.
    Liu HS; Xiao HS
    World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
    Mu YP; Sun WJ; Lu CW; Su XL
    Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
    Beeharry MK; Liu WT; Yan M; Zhu ZG
    World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.